Market Place
Sourcing Support
All News #Library
Biotech
Immunis Announces Phase 2 Results for Secretome-Based Weight Loss
14 Jan 2026 //
BUSINESSWIRE
Immunis Named Top 50 Healthcare Tech Company Of 2025
21 Nov 2025 //
BUSINESSWIRE
Immunis Reports Fat Loss and Liver Recovery in Aged Study Models
31 Oct 2025 //
BUSINESSWIRE
Immunis Receives 2025 National Academy Of Medicine Healthy
02 Oct 2025 //
PHARMAWEB
Immunis Named Top 25 Biotech & Life Sciences Firm for 2025
14 Aug 2025 //
BUSINESSWIRE
Immunis Becomes Semifinalist in XPRIZE Healthspan
12 May 2025 //
BUSINESSWIRE
Immunis’ Treats its First Patients for Sarcopenic Obesity
04 Mar 2025 //
BUSINESSWIRE
Immunis Closes $25 Million Series A-1 Financing Round
12 Jan 2025 //
BUSINESSWIRE
Immunis Completes Ph 1/2a Trial for Muscle Atrophy
19 Nov 2024 //
BUSINESSWIRE
Vaccine bond raises $1 bln for immunisations after record demand
24 Oct 2024 //
REUTERS
FDA Clears Immunis` Phase II Sarcopenic Obesity Trial
10 Sep 2024 //
BUSINESSWIRE
Immunis Chairman Dr. Hans Keirstead to Present at the 2024 Biotech Showcase
04 Jan 2024 //
BUSINESSWIRE
Immunis Wins BASA Biotech Awards: “Best Small Business” & “Best Entrepreneur”
20 Dec 2023 //
BUSINESSWIRE
Immunis Chairman Dr. Hans Keirstead to Present at Festival of Biologics in Basel
26 Sep 2023 //
BUSINESSWIRE
Immunis Releases Video Showcasing its Advanced Biotech Infrastructure
12 Jul 2023 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.